100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Other Events, Press Release
Annual Report to Security Holders
Abbott Laboratories Issues $20 Billion in Senior Notes
Abbott Laboratories Enters $20 Billion Senior Notes Pricing Agreement
Abbott Laboratories Amends Board Composition in By-Laws
Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
BY-LAWS OF Adopted by the Board of Directors at the Annual Meeting, April 11, 1963 as amended and restated, effective December 12, 2025
Notice of Blackout Period to Directors and Executive Officers
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Free Writing Prospectus
Specialized Disclosure Report
Submission Upload
Correspondence